Laura L. Flippin, Partner with DLA Piper LLP to Speak at The Knowledge Group’s FCPA/Anti-Corruption Compliance in Pharma/Life Sciences Industry

New York, NY, June 30, 2016 --(PR.com)-- The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that Laura L. Flippin, Partner with DLA Piper LLP will speak at The Knowledge Group’s webcast entitled: “FCPA/Anti-Corruption Compliance in Pharma/Life Sciences Industry.” This event is scheduled for October 6, 2016 from 12:00pm – 2:00pm (ET).

For further details, please visit: https://theknowledgegroup.org/event/?ID=fcpaanti-corruption-compliance-in-pharmalife-sciences-industry-live-webcast

About Laura L. Flippin

Laura Flippin focuses her practice on government investigations, corporate internal investigations and compliance, anti-bribery and anti-corruption matters, and sanctions and export controls.

She has represented and defended corporations and individuals in a number of industries, including oil and gas, financial, energy, higher education, hospitality and leisure, healthcare, pharmaceutical, engineering and telecommunications. She has appeared in trial and appellate courts throughout the United States in a variety of matters.

Her experience also includes working with clients on sophisticated electronic discovery issues, including preparing for and responding to litigation and government investigations. She has advised and represented companies in a wide variety of compliance matters, including the Foreign Corrupt Practices Act (FCPA), the UK Bribery Act, sanctions and export controls regimes, and the False Claims Act, both in developing and enhancing compliance programs and in responding to government inquiries and investigations. She has also represented telecommunications institutions, government contractors, healthcare providers, life sciences, financial and banking institutions in litigation and investigations involving fraud and compliance issues.

About DLA Piper LLP

DLA Piper is a global law firm with lawyers located in more than 30 countries throughout the Americas, Europe, the Middle East, Africa and Asia Pacific, positioning us to help companies with their legal needs anywhere in the world.

We strive to be the leading global business law firm by delivering quality and value to our clients.

We achieve this through practical and innovative legal solutions that help our clients succeed. We deliver consistent services across our platform of practices and sectors in all matters we undertake.

Our clients range from multinational, Global 1000, and Fortune 500 enterprises to emerging companies developing industry-leading technologies. They include more than half of the Fortune 250 and nearly half of the FTSE 350 or their subsidiaries. We also advise governments and public sector bodies.

Abstract

The U.S. and international enforcement authorities have demonstrated continued focus on the life sciences industry for FCPA and anti-corruption violations as shown by prominent international investigations and intensified government compliance outlooks. This emphasis may be mainly critical for mid-market businesses with underdeveloped compliance programs. Clinical research organizations, hospitals, and providers have also high enforcement risks due to healthcare globalization.

Life Sciences companies should know how to respond to this daunting climate and, eventually, battle anti-corruption risk factors which are confronting the industry.

In this two-hour Live Webcast, a panel of distinguished professionals and thought leaders organized by The Knowledge Group will help Pharma/Life Sciences Industry understand the fundamental and complex aspects of this significant topic. They will provide an in-depth discussion of the various FCPA/Anti-Corruption compliance issues every Pharma/Life Sciences company should know. Speakers will also offer the audience with best practices in developing and implementing an effective compliance and risk management program.

Key topics include:

- FCPA/Anti-Corruption in Pharma/Life Sciences Industry: Current Trends
- Notable Cases for Guidance
- Common Anti-Corruption Risks
- Best Compliance Practices
- Risk Factor Management

About The Knowledge Group/The Knowledge Congress Live Webcast Series

The Knowledge Group was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register for an event, please visit: http://theknowledgegroup.org/.